3. Measles, Mumps, and Rubella

3 Measles Mumps, - Virus associated with skin and mucous membrane infections Measles Human Herpes virus 6 7 Parvovirus B19 Smallpox Molluscum

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: Virus associated with skin and mucous membrane infections Measles Human Herpes virus - 6, 7 Parvovirus B19 Smallpox Molluscum Contagiosum Enteroviruses Virus Infections of the Skin and Mucous Membranes Mumps Rubella Herpes Simplex Varicella Zoster Virus Epstein Barr Virus Measles, Mumps, Rubella Common Features: humans are the only natural host world wide distribution live virus vaccines available late winter, early spring immunity after on attack (vaccine) is life long RNA viruses; single serologic type: Paramyxovirus (Measles, Mumps) Togavirus (Rubella) Measles, Mumps, Rubella Common Features: Transmission - direct contact, respiratory droplet spread Pathogenesis: respiratory tract replicates locally lymph nodes viremia skin, mucous membranes (measles) salivary glands, CNS (mumps) skin, internal organs (rubella) Measles ( Rubeola) Virus (Rubeola) General Characteristics: recent outbreaks in 1989, 1991 - 2, 1995 - Ontario 1991& Quebec 1 0 vaccine failure importation of cases failure to immunize everyone waning immunity (20 vaccine failure) epidemics every 2 -5 years, however it is now a 2rare disease in North America Measles ( Rubeola) Virus (Rubeola) Clinical Manifestations: incubation period 10 - 14 days; rarely asymptomatic infectious 3 days before to 5 days after rash 20 attack rate >90% 7 - 10 days from late prodrome to complete recovery Measles (Rubeola) Virus (Rubeola) Measles ( Rubeola) Virus (Rubeola) Clinical Manifestations: Prodrome - fever, malaise, anorexia, conjunctivitis, cough, coryza Koplik spots - mucous membranes (enanthem); (enanthem); before skin rash; persists for several days Rash - 2 -3 days later; starts at hairline, and spreads down; erythematous, maculopapular; lasts about 5 erythematous, maculopapular; days; desquamation; no scarring Atypical Measles: occurs in person who received killed virus vaccine (1963 - 1967) then exposed to natural measles prodrome - fever and pain x 1 - 2 days rash begins peripherally (hands / feet) more severe / prolonged than usual; pneumonia, hepatitis 2 0 to hypersensitivity in partially immune host immunize with live vaccine in those who received killed vaccine Measles ( Rubeola) Virus (Rubeola) Complications: 'd in adults, malnourished children, immunocompromised, immunocompromised, infants < 1 year pneumonia, otitis media in 10% of cases bacterial superinfection encephalitis (1 in 1000 cases) - 4 -7 days after rash; measles in brain but also autoimmune demyelination mortality - 1 in 3000 cases pregnancy - more severe; no congenital anomalies but spontaneous miscarriage or premature labour Measles ( Rubeola) Virus (Rubeola) Subacute sclerosing panencephalitis (SSPE): chronic degenerative disease occurring years after an attack of measles (usually children <2 yrs) due to persistent infection with measles virus in CNS rare if vaccinated fatal Measles ( Rubeola) Virus (Rubeola) Diagnosis and Treatment: clinical suspicion - coryza, conjunctivitis, koplik spots coryza, and maculopapular rash virus isolation - throat washing, blood, urine direct demonstration - viral antigen by immunofluorescence in nasopharyngeal aspirates serology - measles IgM no specific therapy; supportive care post - exposure prophylaxis in susceptible persons: immunoglobulin given within 6 days of exposure measles vaccine given within 72 hrs Mumps Clinical Manifestations: incubation period 18 - 21 days; asymptomatic infection common; less infectious than measles fever, parotitis (painful, swollen; unilateral 25%, bilateral 75%), trismus other salivary glands may be involved resolves within 1 week complications: meningitis (10%) orchitis (5- 20%); (5oophoritis (5%); pancreatitis, thyroiditis pancreatitis, pregnancy: no congenital malformations; 'd spontaneous abortion Rubella Mumps Diagnosis and Treatment: serology isolation - CSF, throat washings, blood no specific therapy; treatment supportive Congenital Disease: teratogenic during first 16 wks of pregnancy: 1st 2 months: 40 - 80% abnormal 3rd month: 20 - 40% abnormal 4th month: 10% abnormal main defects are triad of cataracts, nerve deafness, cardiac abnormalities multiple organs affected; fetal growth retardation Rubella Congenital Disease: prevention - screening of females prior to childbearing - vaccinate non -immune non rubella screening of pregnant women in 1st trimester 5 - 15% of women will be antibody negative do NOT vaccinate during pregnancy Rubella Diagnosis and Treatment: rash easily confused with other causes serology IgM antibodies; seroconversion isolation difficult; used in diagnosis of congenital rubella no specific treatment ...
View Full Document

This note was uploaded on 05/09/2010 for the course LMP 232 taught by Professor Crandall during the Spring '10 term at University of Toronto- Toronto.

Ask a homework question - tutors are online